Carlos A. Castaneda - Publications

Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: March 11, 2026

Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results.

Journal: Breast (Edinburgh, Scotland)

Published: October 08, 2025

Giant Primary Hepatic Endodermal Sinus Tumor: Multidisciplinary Management and Long-Term Survival.

Journal: Case reports in oncological medicine

Published: September 20, 2025

Real-World Experience of HER2-Positive Advanced Breast Cancer (ABC) Treatment and Evaluation of Blood Biomarkers in a Public Institution in Latin America (LATAM).

Journal: Breast cancer : basic and clinical research

Published: January 07, 2025

First-Line (1L) Treatment Decision Patterns and Survival of Hormone Receptor (HR)-Positive/HER2-Negative Advanced Breast Cancer (ABC) Patients in a Latin American (LATAM) Public Institution.

Journal: Current oncology (Toronto, Ont.)

Published: October 07, 2024

Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: August 22, 2024

Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Journal: The breast journal

Published: August 14, 2024

Impact on Survival with Immunotherapy and Evaluation of Biomarkers in Peruvian Patients with Advanced Melanoma.

Journal: OncoTargets and therapy

Published: June 21, 2024

Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer.

Journal: International journal of breast cancer

Published: February 27, 2024

Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer.

Journal: World journal of gastrointestinal oncology

Published: February 07, 2024

Clinicopathological features associated with CD44 and CD63 expression in breast cancer.

Journal: Ecancermedicalscience

Published: January 22, 2024

Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia.

Journal: International journal of molecular sciences

Published: August 30, 2023